Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies.
about
Using semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters to evaluate tumor hypoxia: a preclinical feasibility study in a maxillofacial VX2 rabbit modelPharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors.Leveraging the power of ultrasound for therapeutic design and optimization.Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor.Magnetic resonance perfusion imaging in neuro-oncology.Spatial registration of temporally separated whole breast 3D ultrasound images.Magnetic resonance imaging in central nervous system tuberculosis.Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.On the relationship between the apparent diffusion coefficient and extravascular extracellular volume fraction in human breast cancerApplications of molecular MRI and optical imaging in cancer.Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas.Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research.Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastasesAdvances in bladder cancer imaging.Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparisonQuantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesionsDynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.Head and neck paragangliomas: diffusion weighted and dynamic contrast enhanced magnetic resonance imaging characteristics.Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: I. SimulationsTexture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerAdvanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review.Modeling and reconstruction of mixed functional and molecular patternsNew developments in MRI for target volume delineation in radiotherapy.The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.Value of Dynamic Contrast-Enhanced MRI to Detect Local Tumor Recurrence in Primary Head and Neck Cancer Patients.Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.Alpha-v integrins as therapeutic targets in oncology.Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer.MRI of the prostate: clinical relevance and emerging applications.A molecular imaging primer: modalities, imaging agents, and applications.MRI of ovarian masses.Multidimensional MR spectroscopic imaging of prostate cancer in vivo.Graphene-based nanomaterials as molecular imaging agents.Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer ModelIn Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
P2860
Q30409908-438A094B-3D90-40DA-A37F-17366B542EF2Q30455361-7E474856-18FE-420F-B380-87E8EC6DA287Q30459779-6631BEC7-3843-4CCE-BADC-4AF19EE3FF25Q30467256-F4917848-08AD-4508-A4D1-2221F952841BQ30479156-7C5AB925-5BAD-4E88-8196-B99C4E8A4C1AQ30479777-A0EECAC4-3893-43E5-8909-48016EABDC37Q33555695-B702D037-B3B5-4974-B4F1-04400F7613D0Q33809311-DC1FC5BF-D7E1-447D-AC2C-8CCA8E75C7DFQ33885391-60BD448A-26A6-4F12-A1E9-0899921592B4Q33986159-F7B774B9-F86F-4020-9CDC-B2419631C1EDQ34054649-AF75F542-851C-4EEF-9517-0F9E3EE4C9A5Q34183087-8DCC120A-C83A-4780-B110-949C582589DFQ34251711-2D2C3DF5-BA6E-49E8-AC62-A470433174A2Q34552360-9D49A378-06EC-4773-A9D6-C7C3B063789FQ34575787-BE653741-315C-4590-88AF-31988C9CAF78Q34662750-54463742-B80A-4C60-A53B-6F693B2A1E54Q35009084-26279D33-1FF4-455B-89D4-44A27D156C77Q35048378-77DC6181-09B5-44A9-839E-1CD8DF2B6FC1Q35077659-D302FBA0-161A-43A1-AB18-0C9D09FC33E2Q35911325-16D97699-A581-4251-999F-B8739A34810EQ35925126-CB86AAE8-B74E-4696-B1DC-11589EE7FEA1Q35936550-8980A9E4-02CA-438F-9734-E1418DC83320Q36497440-983E783E-4800-4756-AC6C-1B49962B6587Q36515722-5C524931-8FCD-41E3-B8E4-A38D7C197257Q36528319-0CAE4F9C-5849-42F7-BAF6-BBB38137853AQ36572384-FAD98F1E-D5D1-458B-A630-E47DC133F525Q36596308-42AB99B0-B44D-4330-A557-6D75F66D5A16Q36616812-A93DE931-9398-4F4C-AC66-0521BDE41997Q36993641-51FF2A50-7BC1-46DB-B25F-9D676C1E5801Q36994280-79EEB24B-00BE-42F3-BD9B-97341B047EE9Q37008623-5DEEC3F3-7566-4DF1-9883-D977C6CA8AE4Q37768170-AF51E6BE-F046-403D-9942-32911A702EB6Q37833011-DBB2F7F4-F906-4F0F-9155-41DB3C889D4EQ38005672-28EB10CF-FCD3-4C7F-B198-18D82A80DF20Q38077164-5093BC01-C6DA-4334-9E53-8F2D14CC00EBQ38125636-A5AF5B7F-A93E-4210-9704-CF8C609FD12BQ38413308-629FD0A6-8FE0-4FBA-B53C-0DB16CE21F89Q38670392-5812FBC7-5BB7-4C11-8312-14767217DB31Q38891146-C8A59133-0BD0-40BB-B608-C2D39A301A54Q38902139-204C481E-69E7-412D-B83A-806C380C45D8
P2860
Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dynamic contrast-enhanced MRI ...... validation and human studies.
@ast
Dynamic contrast-enhanced MRI ...... validation and human studies.
@en
Dynamic contrast-enhanced MRI ...... validation and human studies.
@nl
type
label
Dynamic contrast-enhanced MRI ...... validation and human studies.
@ast
Dynamic contrast-enhanced MRI ...... validation and human studies.
@en
Dynamic contrast-enhanced MRI ...... validation and human studies.
@nl
prefLabel
Dynamic contrast-enhanced MRI ...... validation and human studies.
@ast
Dynamic contrast-enhanced MRI ...... validation and human studies.
@en
Dynamic contrast-enhanced MRI ...... validation and human studies.
@nl
P356
P1433
P1476
Dynamic contrast-enhanced MRI ...... validation and human studies.
@en
P2093
Husband JE
Padhani AR
P304
P356
10.1053/CRAD.2001.0762
P577
2001-08-01T00:00:00Z